- Investing Ideas
- /
- U.K. Pharmaceuticals & Biotech Precious Metals
U.K. Pharmaceuticals & Biotech Precious Metals
UPDATED Mar 26, 2024
Gold, Silver and Precious Metals companies ordered by Snowflake size.
15 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
AZN | UK£104.40 | 2.1% | -6.2% | UK£161.8b | UK£127.54 | PE34.3x | E16.5% | 2.2% | ||
GSK | UK£16.98 | 3.1% | 19.5% | UK£69.4b | UK£19.89 | PE14.1x | E9.4% | 3.4% | ||
HIK | UK£18.65 | -4.3% | 13.3% | UK£4.1b | UK£22.94 | PE27.5x | E18.1% | 3.1% | ||
DXRX | UK£1.04 | 2.5% | 0.5% | UK£87.8m | UK£1.67 | PE14638.3x | E59.5% | n/a | ||
NIOX | UK£0.64 | -5.0% | 44.1% | UK£271.0m | n/a | PE28.5x | E16.9% | 1.6% | ||
HCM | UK£2.64 | -2.6% | 20.5% | UK£2.3b | UK£4.29 | PE28.2x | E19.0% | n/a | ||
EAH | UK£0.84 | -0.6% | -14.2% | UK£57.2m | UK£1.85 | PB0.7x | E46.4% | 0% | ||
STX | UK£0.02 | -5.9% | -66.5% | UK£15.6m | n/a | PS2.7x | E86.9% | n/a | ||
HVO | UK£0.29 | -1.4% | 101.4% | UK£198.7m | n/a | PE69.1x | E29.5% | n/a | ||
APH | UK£0.39 | 6.0% | -40.0% | UK£211.6m | n/a | PS1.2x | E46.4% | 0% | ||
ERGO | UK£13.46 | 0.1% | 3.5% | UK£701.1m | UK£14.34 | PE46.7x | E14.2% | n/a | ||
TRX | UK£0.63 | -1.6% | 9.6% | UK£44.0m | UK£1.20 | PS1.9x | E131.3% | n/a | ||
ANCR | UK£2.02 | -2.4% | 28.3% | UK£121.4m | UK£3.20 | PE104.3x | E20.9% | 2.2% | ||
SAR | UK£0.14 | -14.7% | -83.4% | UK£10.2m | UK£1.76 | PB8.8x | E90.5% | n/a | ||
BVX | UK£0.12 | 0% | -21.7% | UK£9.7m | n/a | PB3.4x | E63.8% | n/a |
Page 1 of 1